ADAMTS16 and ovarian cancer: Our future investigation to reveal this mechanism will surely bring new insight of chemotherapy in recurrent ovarian cancer patients because therapy approaching to tumor microenvironment would be crucial to cancer cells and administering drug against ADAMTS16 is safer than drugs targeting whole matrix metalloproteinases.